McConnaughey Mona M, Sheets Kathryn Ann, Davis Julianne, Privette Jonathan, Hickner Robert, Christian Brandon, Barakat Hisham
Department of Medicine, Brody School of Medicine, East Carolina University, Greenville, NC, USA.
Metabolism. 2004 Feb;53(2):247-51. doi: 10.1016/j.metabol.2003.09.014.
African American women lose less weight and at a slower rate than Caucasian women under the same weight loss conditions. This is likely due to decreased mobilization of fat, possibly involving differences in the responsiveness of adipose tissue to adrenergic stimulation. To better understand the causes behind the decreased lipolysis in African American women, this study was initiated to determine if there were differences in the numbers and affinities of beta adrenoreceptors in omental and subcutaneous adipose tissue of obese African American and Caucasian women. We determined the number of beta receptors using a nonselective antagonist and found the total number of receptors in both omental and subcutaneous adipose tissue preparations were higher in African American than Caucasian women. beta(1)(,) beta(2), and beta(3) densities were higher in omental adipose tissue (P <.05), but not different in the subcutaneous tissue of the African American women. No racial differences in kd values for adrenergic agents (agonists and antagonists) were found with regard to beta(1), beta(2), or beta(3) receptors in either the omental or the subcutaneous preparations. beta(1) and beta(2) receptor protein (mass) was significantly increased in African American omental tissue preparations, but not subcutaneous. Our in vitro data demonstrating increased beta receptor numbers in omental tissue from obese African Americans suggest that the potential for lipolysis would be higher in these women. Future studies should determine the biologic significance of the differences in the beta adrenergic receptors in vivo.
在相同的减肥条件下,非裔美国女性比白人女性减肥更少且速度更慢。这可能是由于脂肪动员减少,可能涉及脂肪组织对肾上腺素能刺激的反应性差异。为了更好地理解非裔美国女性脂肪分解减少背后的原因,开展了本研究,以确定肥胖的非裔美国女性和白人女性网膜及皮下脂肪组织中β肾上腺素能受体的数量和亲和力是否存在差异。我们使用非选择性拮抗剂确定了β受体的数量,发现非裔美国女性网膜和皮下脂肪组织制剂中的受体总数均高于白人女性。网膜脂肪组织中β1、β2和β3密度更高(P<0.05),但非裔美国女性皮下组织中的密度无差异。在网膜或皮下制剂中,就β1、β2或β3受体而言,未发现肾上腺素能药物(激动剂和拮抗剂)的kd值存在种族差异。非裔美国网膜组织制剂中β1和β2受体蛋白(质量)显著增加,但皮下组织中未增加。我们的体外数据表明,肥胖非裔美国人网膜组织中β受体数量增加,这表明这些女性的脂肪分解潜力更高。未来的研究应确定体内β肾上腺素能受体差异的生物学意义。